Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion type Assertion NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_head.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion description "[However, transcripts derived from the MDR1 USP were detected in some drug-resistant cell lines and a high proportion of primary breast tumors (71.6%; n = 61), whereas they were present at low frequency in normal breast tissue (10%; n = 10).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_provenance.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion evidence source_evidence_literature NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_provenance.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion SIO_000772 15102684 NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_provenance.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion wasDerivedFrom befree-20140225 NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_provenance.
- NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_assertion wasGeneratedBy ECO_0000203 NP239391.RAf5-3HU163SCMl9AYM25Dv-eLJHPTB3qUa2w-nngz9ds130_provenance.